Doximity Insider Sells $51,000 in Shares

Siddharth Sitaram, a Doximity insider, sold over 2,400 shares of the company's stock.

Apr. 14, 2026 at 10:40pm by

Got story updates? Submit your updates here. ›

A high-contrast, close-up image of the heavy, industrial gears and mechanisms of a banking vault, representing the institutional power and security of the financial system as a metaphor for the insider transaction involving the Doximity digital healthcare platform.An insider's sale of Doximity shares highlights the complex financial machinery powering the digital healthcare platform.San Francisco Today

Doximity, Inc. (NYSE:DOCS) insider Siddharth Sitaram sold 2,427 shares of the company's stock on April 10th, 2026. The shares were sold at an average price of $21.09, for a total transaction value of $51,185.43. Following the sale, Sitaram still owns 86,705 shares in the company, valued at approximately $1.8 million.

Why it matters

Insider transactions, especially sales, can provide insights into management's views on a company's prospects. This sale by a Doximity insider may signal some caution about the stock's near-term performance, even as the company continues to grow its digital healthcare platform.

The details

The stock sale was executed under a pre-arranged 10b5-1 trading plan, which allows insiders to sell shares on a scheduled basis to avoid allegations of insider trading. Sitaram cited the need to cover tax withholding obligations related to the vesting of his equity awards as the reason for the sale.

  • The shares were sold on Friday, April 10th, 2026.

The players

Siddharth Sitaram

A Doximity insider who sold 2,427 shares of the company's stock.

Doximity, Inc.

A digital healthcare platform that connects physicians and other medical professionals.

Got photos? Submit your photos here. ›

What they’re saying

“The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.”

— Siddharth Sitaram

The takeaway

This insider sale, while routine, may indicate some caution about Doximity's near-term prospects among company insiders. Investors should monitor the stock's performance and any further insider transactions for clues about the company's future direction.